One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel.
作者信息
Boateng Lilian A, Schonewille Henk, Ligthart Peter C, Javadi Ahmad, Veldhuisen Barbera, Osei-Akoto Alex, Dei-Adomakoh Yvonne, Bates Imelda, Van der Schoot C Ellen
机构信息
Centre for Capacity Research, International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi.
Experimental Immunohaematology, Sanquin, Amsterdam.
出版信息
Haematologica. 2021 Aug 1;106(8):2274-2276. doi: 10.3324/haematol.2021.278451.
Abstract
摘要
相似文献
1
One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel.
Haematologica. 2021 Aug 1;106(8):2274-2276. doi: 10.3324/haematol.2021.278451.
2
Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
Transfusion. 2021 Aug;61(8):2255-2264. doi: 10.1111/trf.16444. Epub 2021 May 17.
3
Case reports: delayed hemolytic transfusion reaction in sickle cell disease.
Am J Med Sci. 1996 Oct;312(4):175-81. doi: 10.1097/00000441-199610000-00005.
4
Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria.
Niger J Clin Pract. 2015 Jul-Aug;18(4):522-6. doi: 10.4103/1119-3077.154204.
5
Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
Br J Haematol. 2015 Jul;170(2):247-56. doi: 10.1111/bjh.13424. Epub 2015 Apr 19.
6
[Red blood cell immunization in haemoglobinopathie: about 84 cases].
Transfus Clin Biol. 2012 Dec;19(6):345-52. doi: 10.1016/j.tracli.2012.06.006. Epub 2012 Oct 25.
7
Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital.
Transfus Apher Sci. 2012 Dec;47(3):253-7. doi: 10.1016/j.transci.2012.07.014. Epub 2012 Sep 13.
8
[Transfusion and alloimmunization in sickle cell anemia patients].
Transfus Clin Biol. 1994;1(1):27-34. doi: 10.1016/s1246-7820(05)80054-0.
9
Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
Transfusion. 2009 Aug;49(8):1649-54. doi: 10.1111/j.1537-2995.2009.02185.x.
10
Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Transfus Med Rev. 2019 Jan;33(1):12-23. doi: 10.1016/j.tmrv.2018.07.003. Epub 2018 Jul 26.
引用本文的文献
1
The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low- and middle-income countries.
Br J Haematol. 2025 Jun;206(6):1585-1592. doi: 10.1111/bjh.20055. Epub 2025 Mar 27.
2
First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa.
Blood Transfus. 2024 Sep;22(5):377-386. doi: 10.2450/BloodTransfus.660. Epub 2024 Jan 29.
3
Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells.
Blood Adv. 2024 Mar 26;8(6):1449-1463. doi: 10.1182/bloodadvances.2023011708.
4
Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion.
Blood Adv. 2023 Dec 26;7(24):7608-7620. doi: 10.1182/bloodadvances.2022009328.
5
Adverse events of red blood cell transfusions in patients with sickle cell disease.
Transfus Apher Sci. 2022 Oct;61(5):103557. doi: 10.1016/j.transci.2022.103557. Epub 2022 Aug 29.
6
The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine.
Blood. 2022 Oct 13;140(15):1723-1734. doi: 10.1182/blood.2022015883.
7
How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):689-695. doi: 10.1182/hematology.2021000306.
本文引用的文献
1
Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Transfusion. 2019 Jul;59(7):2282-2291. doi: 10.1111/trf.15328. Epub 2019 Apr 25.
2
genotype matching for transfusion support in sickle cell disease.
Blood. 2018 Sep 13;132(11):1198-1207. doi: 10.1182/blood-2018-05-851360. Epub 2018 Jul 19.
3
High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients.
Transfusion. 2018 Jun;58(6):1527-1535. doi: 10.1111/trf.14633. Epub 2018 Apr 29.
4
Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
Transfusion. 2018 Jul;58(7):1588-1596. doi: 10.1111/trf.14588. Epub 2018 Mar 23.
5
Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
Transfusion. 2017 Nov;57(11):2738-2746. doi: 10.1111/trf.14282. Epub 2017 Aug 24.
6
Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.
Transfusion. 2015 Jun;55(6 Pt 2):1399-406. doi: 10.1111/trf.13037. Epub 2015 Mar 9.
7
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
Transfusion. 2015 Jun;55(6 Pt 2):1378-87. doi: 10.1111/trf.12940. Epub 2014 Dec 1.
8
A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease.
Am J Clin Pathol. 2014 Feb;141(2):256-61. doi: 10.1309/AJCP47QAAXTOZEKJ.
9
D category IV: a group of clinically relevant and phylogenetically diverse partial D.
Transfusion. 2013 Nov;53(11 Suppl 2):2960-73. doi: 10.1111/trf.12145. Epub 2013 Mar 5.
10
RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification.
Transfusion. 2013 Jul;53(7):1559-74. doi: 10.1111/j.1537-2995.2012.03919.x. Epub 2012 Oct 9.
Zotero 插件